T1D is characterized by uplifted immune responses targeted against several autoantigens including heat shock protein 60 (Hsp60), insulin, insulinoma-associated protein-2 (IA-2), and pancreatic glutamic acid decarboxylase (GAD65) [56]. This evidence concerns the gene INS and type 1 diabetes mellitus.